Product Information
NADOLOL 40 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2654 per EA under NDC 68382073301. Its NADAC has been published 456 times since Jan 10, 2018.
FDA first approved this application on Jul 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382073301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NADOLOLApproval Type
Generic (ANDA)
FDA Application
ANDA207761FDA Approved
7/28/2017
TE Code
AB
On Market Since
8/8/2017
Pharmacological Classes
Price Statistics
The NADAC for NADOLOL 40 MG TABLET has been published 456 times since Jan 10, 2018, and over the history we have for it it has declined 83.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2654 per EA |
|---|---|
| All-time high | $1.8013 (Mar 14, 2018) |
| All-time low | $0.2128 (Jul 17, 2024) |
| 52-week high | $0.3268 |
| 52-week low | $0.2390 |
| Median price | $0.4013 |
| Average price | $0.5337 |
| Largest weekly change | +67.6% (Aug 21, 2024) |
| Weeks tracked | 456 |
| Tracking since | Jan 10, 2018 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nadolol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NADOLOL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NADOLOL 40 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2654 per EA (NDC 68382073301), effective Sep 30, 2026.
How has the price of NADOLOL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for NADOLOL 40 MG TABLET has declined 83.9%. It has been tracked across 456 weekly CMS publications since Jan 10, 2018.
What are the highest and lowest recorded NADAC prices for NADOLOL 40 MG TABLET?
Since Jan 10, 2018, the NADAC for NADOLOL 40 MG TABLET has ranged from a low of $0.2128 (Jul 17, 2024) to a high of $1.8013 (Mar 14, 2018), with a median of $0.4013 per EA.
Are there cheaper alternatives to NADOLOL 40 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NADOLOL 40 MG TABLET, is $0.2390 per EA — about 10% below NADOLOL 40 MG TABLET.
Who manufactures NADOLOL 40 MG TABLET?
NADOLOL 40 MG TABLET (NDC 68382073301) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.